compound 31 [PMID: 24809814]   Click here for help

GtoPdb Ligand ID: 8465

Synonyms: 
PDB Ligand
Compound class: Synthetic organic
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 0
Rotatable bonds 4
Topological polar surface area 68.94
Molecular weight 454.17
XLogP 6.32
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES N#Cc1ccc(nc1)N1CCN(CC1C)c1nnc(c2c1cc(Cl)cc2)Cc1ccccc1
Isomeric SMILES N#Cc1ccc(nc1)N1CCN(C[C@H]1C)c1nnc(c2c1cc(Cl)cc2)Cc1ccccc1
InChI InChI=1S/C26H23ClN6/c1-18-17-32(11-12-33(18)25-10-7-20(15-28)16-29-25)26-23-14-21(27)8-9-22(23)24(30-31-26)13-19-5-3-2-4-6-19/h2-10,14,16,18H,11-13,17H2,1H3/t18-/m1/s1
InChI Key XUZUIICAPXZZDU-GOSISDBHSA-N
References
1. Harris CM, Mittelstadt S, Banfor P, Bousquet P, Duignan DB, Gintant G, Hart M, Kim Y, Segreti J. (2016)
Sphingosine-1-Phosphate (S1P) Lyase Inhibition Causes Increased Cardiac S1P Levels and Bradycardia in Rats.
J Pharmacol Exp Ther, 359 (1): 151-8. [PMID:27519818]
2. Loetscher E, Schneider K, Beerli C, Billich A. (2013)
Assay to measure the secretion of sphingosine-1-phosphate from cells induced by S1P lyase inhibitors.
Biochem Biophys Res Commun, 433 (3): 345-8. [PMID:23499842]
3. Schümann J, Grevot A, Ledieu D, Wolf A, Schubart A, Piaia A, Sutter E, Côté S, Beerli C, Pognan F et al.. (2015)
Reduced Activity of Sphingosine-1-Phosphate Lyase Induces Podocyte-related Glomerular Proteinuria, Skin Irritation, and Platelet Activation.
Toxicol Pathol, 43 (5): 694-703. [PMID:25630683]
4. Weiler S, Braendlin N, Beerli C, Bergsdorf C, Schubart A, Srinivas H, Oberhauser B, Billich A. (2014)
Orally active 7-substituted (4-benzylphthalazin-1-yl)-2-methylpiperazin-1-yl]nicotinonitriles as active-site inhibitors of sphingosine 1-phosphate lyase for the treatment of multiple sclerosis.
J Med Chem, 57 (12): 5074-84. [PMID:24809814]